| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |